Alliance A031902 (CASPAR): A randomized phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Rao, A.; Heller, G.; Ryan, C. J.; VanderWeele, D. J.; Lewis, L. D.; Tan, A.; Watt, C.; Chen, R. C.; Kohli, M.; Barata, P. C.; Gartrell, B. A.; Grubb, R.; Dueck, A. C.; Wen, Y.; Morris, M. J.
Abstract Title:	Alliance A031902 (CASPAR): A randomized phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title:	2023 ASCO Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	41
Issue:	6 Suppl.
Meeting Dates:	2023 Feb 16-18
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-02-20
Language:	English
DOI:	10.1200/JCO.2023.41.6_suppl.TPS277
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=162007029&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: TPS277 -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/203747